Building the capacity of the National AIDS Control Program of the Ministry of Health to Expand Coordinated HIV Prevention, Care, Treatment, and Strategic Information Programs in the United Republic of Tanzania under the President's Emergency Plan for | CDC RFA GH12 124005CONT17

Opportunity Information: Apply for CDC RFA GH12 124005CONT17

This grant opportunity is a continuation cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Center for Global Health, focused on strengthening the National AIDS Control Program (NACP) within Tanzania's Ministry of Health. The core purpose is to build and expand the government's ability to coordinate and deliver a comprehensive national HIV response under the President's Emergency Plan for AIDS Relief (PEPFAR). In practical terms, the opportunity is aimed at reinforcing Tanzania's national systems so they can plan, manage, and oversee high-quality HIV prevention, care, and treatment services, while also improving the strategic information needed to track the epidemic, guide programming, and demonstrate results.

The funding opportunity (CDC RFA GH12 124005CONT17) is categorized as "Continuation" and uses a cooperative agreement funding instrument. A cooperative agreement generally indicates substantial involvement by CDC in technical direction, collaboration, and oversight compared to a standard grant, reflecting that the work is closely tied to U.S. government public health priorities and must align with PEPFAR policies, targets, and reporting expectations. The activity category is health, and it is associated with CFDA number 93.067, which corresponds to CDC global HIV/AIDS programming. Only one award was expected, signaling that this continuation funding was likely intended to extend or expand an existing, specific recipient's work rather than open a broad competition among many new applicants.

Programmatically, the opportunity centers on four interrelated pillars of the HIV response: prevention, care, treatment, and strategic information. "Prevention" in this context typically covers coordinated approaches that reduce new infections through evidence-based interventions, potentially including combination prevention strategies, targeted services for populations at increased risk, prevention of mother-to-child transmission linkages, and strengthening referral networks. "Care" and "treatment" point to supporting the national program to manage and improve antiretroviral therapy (ART) delivery, retention in care, adherence support, clinical monitoring, and quality improvement across facilities and implementing partners. The emphasis on "coordinated" programming is important: it suggests the work is not only about delivering services, but about improving national leadership, harmonizing partner activities, aligning standards and guidelines, and ensuring consistent implementation across regions and service delivery points.

A significant component of the award is "strategic information," which in HIV programming refers to the data systems and analytic capacity needed to understand where the epidemic is concentrated, how well programs are performing, and what course corrections are needed. This often includes strengthening health information systems, improving data quality, standardizing indicators, enhancing routine reporting, and enabling analysis and use of data for decision-making at national and subnational levels. Strategic information also typically supports surveillance and monitoring and evaluation functions that are central to meeting PEPFAR performance requirements and national planning needs.

From an administrative standpoint, the opportunity was created on October 12, 2016, with an original closing date of December 12, 2016. The listing shows an award ceiling of 0, which commonly indicates the ceiling amount was not specified in the public synopsis or was to be determined through internal budgeting for the continuation action, rather than implying no funding. Eligibility is listed as "Others," with additional eligibility details referenced in the full announcement; this type of language often appears when eligibility is limited or tailored, as can happen with continuation awards where a specific existing awardee may be the intended recipient, or where eligibility depends on meeting particular criteria described in the full notice.

Overall, this funding opportunity is best understood as a targeted continuation investment designed to deepen Tanzania's national capacity to lead and manage a coordinated HIV program at scale, ensuring prevention, care, and treatment services are effectively organized and that the country has strong strategic information functions to monitor progress, guide resources, and improve health outcomes in line with PEPFAR objectives.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Building the capacity of the National AIDS Control Program of the Ministry of Health to Expand Coordinated HIV Prevention, Care, Treatment, and Strategic Information Programs in the United Republic of Tanzania under the President's Emergency Plan for" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Oct 12, 2016.
• Applicants must submit their applications by Dec 12, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH12 124005CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: